Neoadjuvant chemotherapy with cisplatin, aclacinomycin A, and mitomycin C for cervical adenocarcinoma - A preliminary study

International Journal of Gynecological Cancer

Volumn 14, Issue 3, 2004, Pages 483-490

  Saito, Tsuyoshi ^a,b   Takehara, M ^a   Lee, R ^a   Fujimoto, T ^a   Nishimura, M ^a   Tanaka, R ^a   Ito, E ^a   Adachi, K ^a   Kudo, R ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Cervical adenocarcinoma; Chemotherapy; NAC; Radical hysterectomy; Surgery

Indexed keywords

ACLARUBICIN; CISPLATIN; GRANULOCYTE COLONY STIMULATING FACTOR; MITOMYCIN C;

ADENOCARCINOMA; ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; FEMALE; HUMAN; LIVER TOXICITY; LYMPH NODE METASTASIS; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; SURVIVAL RATE; THROMBOCYTOPENIA; UTERINE ARTERY; UTERINE CERVIX CANCER;

ACLARUBICIN; ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MITOMYCIN; NEOADJUVANT THERAPY; NEOPLASM STAGING; PILOT PROJECTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 2942558954     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1048-891x.2004.014309.x     Document Type: Article

References (25)

1. Buckley C, Fox H. Pathology of Clinical Invasive Carcinoma of Cervix. Edinburgh: Churchill Livingstone, 1992.
2. Kjorstad KE, Bond B. Stage IB adenocarcinoma of the cervix: metastatic potential and patterns of dissemination. Am J Obstet Gynecol 1984;150:297-9.
3. Weiss RJ, Lucas WE. Adenocarcinoma of the uterine cervix. Cancer 1986;57:1996-2001.
4. Tamimi HK, Figge DC. Adenocarcinoma of the uterine cervix. Gynecol Oncol 1982;13:335-44.
5. Berek JS, Hacker NF, Fu YS, Sokale JR, Leuchter RC, Lagasse LD. Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastasis and survival. Obstet Gynecol 1985;65:46-52.
6. Moberg PJ, Einhorn N, Silfversward C, Soderberg G. Adenocarcinoma of the uterine cervix. Cancer 1986;57:407-10.
7. Saigo PE, Cain JM, Kim WS, Gaynor JJ, Johnson K, Lewis JL, Jr. Prognostic factors in adenocarcinoma of the uterine cervix. Cancer 1986;57:1584-93.
8. Takehara M, Hayakawa O, Saito T et al. Combination chemotherapy with cisplatin, aclacinomycin A, and mytomycin C for primary, advanced, or recurrent cervical adenocarcinoma. J Gynecol Tech 1999;5:151-5.
9. Zanetta G, Lissoni A, Gabriele A et al. Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma. Gynecol Oncol 1997;64:431-5.
10. Iwasaka T, Fukuda K, Hara K et al. Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix. Gynecol Oncol 1998;70:236-40.
11. Bates R, Deppe G, Malone JM, Jr, Budev H, Christensen CW, Malviya VK. Combination chemotherapy for advanced adenocarcinoma of the cervix. Cancer 1991;68:747-50.
12. Benedetti-Panici P, Maneschi F, Cutillo G et al. Modified type IV-V radical hysterectomy with systematic pelvic and aortic lymphadenectomy in the treatment of patients with stage III cervical carcinoma. Feasibility, technique, and clinical results. Cancer 1996;78:2359-65.
13. Dottino PR, Plaxe SC, Beddoe AM, Johnston C, Cohen CJ. Induction chemotherapy followed by radical surgery in cervical cancer. Gynecol Oncol 1991;40:7-11.
14. Scarabelli C, Zarrelli A, Gallo A, Visentin MC. Multimodal treatment with neoadjuvant intraarterial chemotherapy and radical surgery in patients with stage IIIB-IVA cervical cancer. A preliminary study. Cancer 1995;76:1019-26.
15. Creasman WT. New gynecologic cancer staging. Gynecol Oncol 1995;58:157-8.
16. Yamashita Y, Takahashi M, Bussaka H et al. Balloon-occluded arterial infusion therapy in the treatment of primary and recurrent gynecologic malignancies. Cardiovasc Intervent Radiol 1989;12:188-95.
17. Tobinai K, Kohno A, Shimada Y et al. Toxicity grading criteria of the Japan Clinical Oncology Group. The Clinical Trial Review Committee of the Japan Clinical Oncology Group. Jpn J Clin Oncol 1993;23:250-7.
18. Hopkins MP, Morley GW. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 1991;77:912-7.
19. Kjorstad KE. Adenocarcinoma of the uterine cervix. Gynecol Oncol 1977;5:219-23.
20. Milsom I, Friberg LG. Primary adenocarcinoma of the uterine cervix. A clinical study. Cancer 1983;52:942-7.
21. Berek JS, Castaldo TW, Hacker NF, Petrilli ES, Lagasse LD, Moore JG. Adenocarcinoma of the uterine cervix. Cancer 1981;48:2734-41.
22. Takehara M, Hayakawa O, Kudo R. [Experimental and clinical study on chemotherapy for cervical adenocarcinoma]. Nippon Sanka Fujinka Gakkai Zasshi 1995;47:405-12.
23. Wheelock JB, Krebs HB, Goplerud DR, Myers M. Cis-platinum, doxorubicin, and methotrexate treatment for recurrent cervical cancer. Obstet Gynecol 1985;66: 410-2.
24. Kavanagh JJ, Gershenson D, Copeland L, Roberts WS. Combination chemotherapy for metastatic or recurrent adenocarcinoma of the cervix. J Clin Oncol 1987;5:1621-3.
25. Fujiwaki R, Takahashi K, Kitao M. Decrease in tumor volume and histologic response to intraarterial neoadjuvant chemotherapy in patients with cervical and endometrial adenocarcinoma. Gynecol Oncol 1997;65:258-64.